Delivery Order SPE2DB22D2005-SPE2DB25FJLZ2

Award Date 5/6/25
Potential Completion Date 5/7/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,226.31 firm fixed-price delivery order covers the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is a delivery order worth $1,020.98 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,729.58, is for the delivery of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product. This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.89, is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,101.32, is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of March 11, 2025 and is not designated as a set-aside. The contract provides for the delivery of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product, to support federal government...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Reyvow (100 mg tablet) and has a ceiling value of $1,527.15. It is a firm fixed-price contract with an ultimate completion date of May 12, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,236.30, is a Delivery Order contract for the provision of REYVOW 100 MG TABLET UD 8S medical supplies. The contract has a completion date of June 26, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,421.88, is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at $999,999,999 and runs through November 2026. The contract is for the supply of REYVOW 100 MG TABLET UD 8S, a prescription medication, to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,226.28 firm fixed-price delivery order is for the supply of REYVOW 50 MG TABLET UD 8S, a prescription medication. The contract has an ultimate completion date of June 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,226.28, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S medical products, with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen holds a significant...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJLZ2
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a ceiling value of $1,549.05 and a performance period ending on May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/10/25, 1:14 AM